Outcomes in surgery for ovarian cancer

Gynecologic Oncology

Volumn 87, Issue 3, 2002, Pages 260-267

  Elit, Laurie ^a,b   Bondy, S J ^c,d   Paszat, L ^a,c,e,f   Przybysz, R ^c   Levine, M ^a,b  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DATA BASE; FEMALE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; SURGEON; SURGICAL RISK; TREATMENT OUTCOME;

EID: 0036921829     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6834     Document Type: Article

References (14)

1. National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, Health Canada. Canadian Cancer Statistics 13-19 1998. [Abstract]
2. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A gynecologic oncology group study. Gynecol Oncol 1992;47:159-66.
3. Hoskins WJ. Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993;71:1534-40.
4. Simunovic M, To T, Theriault M, Langer B. Hospital volume-outcome relationships in pancreatic resection for neoplasm in a publicly-funded health care system. Can Med J 1999;160:643-8.
5. Royall, RM. Model robust confidence intervals using maximum likelihood estimators. Int Statist Rev 1986;54:221-6.
6. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Statist Assoc 1989;84:1074-8.
7. Rogers WH. Regression standard errors in clustered samples (sg17). Stata Tech Bull Repr 1993;3:88-94.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-83.
9. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 2000;18:2327-40.
10. Hole DJ, Gillis CR. Use of cancer registry data to evaluate the treatment of ovarian cancer on a hospital basis. Health Rep 1993;5:117-9.
11. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 1997;15:3408-15.
12. Nguyen HN, Averette HE, Hoskins W, Penalver M, Sevin BU, Steren A. National survey of ovarian carcinoma: V. The impact of physician's specialty on patients' survival. Cancer 1993;72:3663-70.
13. Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: Referral to a multidisciplinaryteam matters. Br J Cancer 1994;70:363-70.
14. Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang H. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol 1992;47:203-9.